1. He, Xiaoman, Li, Yongzhou, Chen, Qing, Zhu, Yi, Wu, Yulian. 2022. O-GlcNAcylation and stablization of SIRT7 promote pancreatic cancer progression by blocking the SIRT7-REGγ interaction. In Cell death and differentiation, 29, 1970-1981. doi:10.1038/s41418-022-00984-3. https://pubmed.ncbi.nlm.nih.gov/35422493/
2. Bi, Shijia, Jiang, Xiaoyu, Ji, Qianzhao, Liu, Guang-Hui, Qu, Jing. 2024. The sirtuin-associated human senescence program converges on the activation of placenta-specific gene PAPPA. In Developmental cell, 59, 991-1009.e12. doi:10.1016/j.devcel.2024.02.008. https://pubmed.ncbi.nlm.nih.gov/38484732/
3. Tang, Ming, Tang, Huangqi, Tu, Bo, Zhu, Wei-Guo. 2021. SIRT7: a sentinel of genome stability. In Open biology, 11, 210047. doi:10.1098/rsob.210047. https://pubmed.ncbi.nlm.nih.gov/34129782/
4. Xiang, Junyu, Zhang, Ni, Sun, Hui, Liu, Chungang, Qian, Cheng. 2019. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells. In Gastroenterology, 158, 664-678.e24. doi:10.1053/j.gastro.2019.10.025. https://pubmed.ncbi.nlm.nih.gov/31678303/
5. Kim, Yuna, Jung, Kwan-Young, Kim, Yun Hak, Auwerx, Johan, Ryu, Dongryeol. 2024. Inhibition of SIRT7 overcomes sorafenib acquired resistance by suppressing ERK1/2 phosphorylation via the DDX3X-mediated NLRP3 inflammasome in hepatocellular carcinoma. In Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy, 73, 101054. doi:10.1016/j.drup.2024.101054. https://pubmed.ncbi.nlm.nih.gov/38277756/
6. Yoshizawa, Tatsuya, Sato, Yoshifumi, Sobuz, Shihab U, Auwerx, Johan, Yamagata, Kazuya. 2022. SIRT7 suppresses energy expenditure and thermogenesis by regulating brown adipose tissue functions in mice. In Nature communications, 13, 7439. doi:10.1038/s41467-022-35219-z. https://pubmed.ncbi.nlm.nih.gov/36509749/
智鼠故事 
